On this page
Overview
Product & regulatory status
FDA-approved prescription enanthate products exist; the exact label determines the approved route and indication.
Ester conversion
Enanthate is converted to testosterone in the body. Esterification changes delivery characteristics, while the active hormone supplies androgen effects. [1]
What the evidence shows
Autoinjector study
Xyosted was evaluated in an open-label, 52-week study of 150 hypogonadal men. At week 12, 90% had average testosterone within the study’s reference range. There was no placebo group demonstrating a symptom benefit. [2]
Cardiovascular evidence is not ester-specific
TRAVERSE enrolled 5,246 men with hypogonadism and cardiovascular disease or elevated risk. Gel was noninferior to placebo for major cardiovascular events; this was not an enanthate trial and does not establish freedom from all adverse effects. [3]
What remains unknown
There is no universal conversion from another testosterone product based only on its name. Individual exposure, symptoms and tolerability require reassessment when the formulation changes.
Safety
Monitoring remains necessary
Xyosted labeling includes increased blood pressure, elevated hematocrit, edema and possible sperm suppression. Its trial findings do not remove those concerns. [2]
Ingredient sensitivity
The cited conventional vial contains sesame oil and chlorobutanol; the autoinjector is a distinct preservative-free product. Allergies require the actual ingredient list. [1]
Use the correct product record
The cited generic vial is labeled for intramuscular use; Xyosted’s evidence concerns its own subcutaneous autoinjector. [2]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [4]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [5]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Are a vial and autoinjector interchangeable?
The same ester does not make the delivery device, ingredients or approved route interchangeable.
What should follow-up assess?
Whether the diagnosed symptoms improve and whether blood pressure, blood counts or reproductive goals change the treatment balance.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Testosterone enanthate multidose-vial labelUS prescribing information · revised June 2025 · DailyMed updated May 2026
- Xyosted prescribing informationUS testosterone-enanthate autoinjector label; 150-patient product trial and safety monitoring.
- Lincoff et al.: TRAVERSENew England Journal of Medicine, 2023; 5,246 men with hypogonadism and cardiovascular disease or elevated risk; transdermal gel trial.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.